Status:
RECRUITING
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Plasma Cell Dyscrasias
Monoclonal Gammopathy of Undetermined Significance
Eligibility:
All Genders
18+ years
Brief Summary
The investigators are researching patients with diseases of their plasma cells in order to improve their quality and length of life. The investigators have created a database of patient information, b...
Detailed Description
The investigators propose to contact and interact with all patients with plasma cell dyscrasias in the State of Ohio (and all patients diagnosed or treated at Ohio State Medical Center) for both surve...
Eligibility Criteria
Inclusion
- Inclusion:
- Diagnosis of a plasma cell dyscrasia
- Exclusion:
- Prisoners are excluded from participation as they have no standard access to the Ohio State myeloma clinic and would impede the research objective of this protocol.
Exclusion
Key Trial Info
Start Date :
March 17 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2050
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT01408225
Start Date
March 17 2011
End Date
March 1 2050
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Medical Center
Columbus, Ohio, United States, 43210